Dynavax Technologies Corp (LTS:0IDA)
$ 12.9401 0 (0%) Market Cap: 1.71 Bil Enterprise Value: 1.20 Bil PE Ratio: 100.00 PB Ratio: 2.51 GF Score: 67/100

Dynavax Technologies Corp at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 10, 2021 / 07:50PM GMT
Release Date Price: $9.4 (+6.16%)
Robert Luis Palermo
Goldman Sachs Group, Inc., Research Division - Research Analyst

Hey, guys, my name is Rob Palermo. I'm part of the biotech research team here at Goldman Sachs. Happy to be here today at the Annual Healthcare Conference with Ryan Spencer, CEO of Dynavax Technologies. We're going to go through presentation today, and then time permitting, we can field some questions if there are any submitted. So how about -- you can take it away, Ryan.

Ryan Spencer
Dynavax Technologies Corporation - CEO & Director

Thanks, Rob. And thank you all for joining us today. I'm Ryan Spencer, Chief Executive Officer of Dynavax Technologies, and I'm excited to share the Dynavax story with you, which, we believe, provides a compelling investment opportunity.

In this corporate overview, we will be making forward-looking statements that are subject to risks and uncertainties as identified on this slide and in our filings with the SEC, which provide details on our business and the associated investment risk, which we encourage you to review.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot